UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Data Collection in Multiple Sclerosis: The MSDS Approach

Frontiers in neurology, 2020-06, Vol.11, p.445-445

2020

Volltextzugriff (PDF)

WED 188 Pangaea 2.0 interim results: switching to fingolimod

Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A27-A27

2018

Volltextzugriff (PDF)

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

Multiple sclerosis, 2018-09, Vol.24 (10), p.1337-1346

2018

Volltextzugriff (PDF)

A Digital Patient Portal for Patients With Multiple Sclerosis

Frontiers in neurology, 2020-05, Vol.11, p.400-400

2020

Volltextzugriff (PDF)

Patients' preferences for involvement in the decision-making process for treating diabetic retinopathy

BMC ophthalmology, 2017-08, Vol.17 (1), p.139-139, Article 139

2017

Volltextzugriff (PDF)

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

Therapeutic advances in chronic disease, 2019, Vol.10, p.2040622319835136-2040622319835136

2019

Volltextzugriff (PDF)

On the Reliability of Examining Dual-Tasking Abilities Using a Novel E-Health Device—A Proof of Concept Study in Multiple Sclerosis

Journal of clinical medicine, 2020-10, Vol.9 (11), p.3423

2020

Volltextzugriff (PDF)

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach

BMC neurology, 2016-08, Vol.16 (1), p.124-124, Article 124

2016

Volltextzugriff (PDF)

The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice

BMC neurology, 2015-06, Vol.15 (1), p.93-93, Article 93

2015

Volltextzugriff (PDF)

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod

BMC neurology, 2016-08, Vol.16 (1), p.129-129, Article 129

2016

Volltextzugriff (PDF)

PANGAEA 2.0: State of the Art Multiple Sclerosis Patient Management in Daily Clinical Practice. A 3-Year Observational Study of Patients Receiving Fingolimod (P3.031)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

Journal of medical Internet research, 2020-03, Vol.22 (3), p.e17921-e17921

2020

Volltextzugriff (PDF)

TREAT-MS Study of Real-World Effectiveness of Alemtuzumab in RRMS Patients in Germany: Subgroup Analysis by Timing of Treatment Initiation (170)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Umsetzung der Nationalen VersorgungsLeitlinie (NVL) zur Therapie des Diabetes mellitus Typ 2 in diabetologischen Schwerpunktpraxen

Deutsche medizinische Wochenschrift, 2017-09, Vol.142 (18), p.e131-e139

2017

Volltextzugriff (PDF)

Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple Sclerosis

Patient preference and adherence, 2024-01, Vol.18, p.455-466

2024

Volltextzugriff (PDF)

Real-World Effectiveness of Alemtuzumab in Relapsing-Remitting MS Patients in Germany: Interim Results of the TREAT-MS Study (P3.2-057)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approach

Expert opinion on drug safety, 2018-04, Vol.17 (4), p.369-378

2018

Volltextzugriff (PDF)

Design of a Non-interventional Study to Establish Effectiveness, Quality of Life, Cognition, Health-Related and Work Capacity Data on Alemtuzumab in Multiple Sclerosis Patients in Germany (TREAT-MS) (P7.281)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Umsetzung der Nationalen VersorgungsLeitlinie (NVL) zur Therapie des Diabetes mellitus Typ 2 in diabetologischen Schwerpunktpraxen: Hohe Übereinstimmung im therapeutischen Alltag

Diabetes aktuell, 2017-10, Vol.15 (6), p.257-270

2017

Volltextzugriff (PDF)

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

BMC neurology, 2016-07, Vol.16 (1), p.109-109, Article 109

2016

Volltextzugriff (PDF)

Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System

Interactive journal of medical research, 2016-01, Vol.5 (1), p.e2-e2

2016

Volltextzugriff (PDF)

Multiple Sclerosis Documentation System MSDS3D - Innovative Management of Patients with Multiple Sclerosis (I8-1.003)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

Multiple Sclerosis Documentation System MSDS3D - Innovative Management of Patients with Multiple Sclerosis (P3.130)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

Implementation of the National Guidelines for the treatment of Diabetes mellitus type 2 in secondary diabetes centers

Deutsche medizinische Wochenschrift (1946), 2017-09, Vol.142 (18), p.e131

2017

Volltextzugriff (PDF)

Limited Time from the Diabetes Patients' Perspective: Need for Conversation with the Eye Specialist

Ophthalmologica (Basel), 2016-01, Vol.236 (3), p.154-158

2016

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(16)

Publikationsform

Sprache

Englisch
(23)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Multiple Sclerosis
(13)
Humans
(8)
Neurosciences & Neurology
(8)
Clinical Neurology
(7)
Care And Treatment
(5)
Female
(4)
Male
(4)
Patients
(4)
Prospective Studies
(4)
Quality Of Life
(4)
Adult
(3)
Cognition
(3)
Drug Therapy
(3)
General & Internal Medicine
(3)
Health Aspects
(3)
Medicine, General & Internal
(3)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(3)
Neurosciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Data Collection in Multiple Sclerosis: The MSDS Approach

WED 188 Pangaea 2.0 interim results: switching to fingolimod

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

A Digital Patient Portal for Patients With Multiple Sclerosis

Patients' preferences for involvement in the decision-making process for treating diabetic retinopathy

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

On the Reliability of Examining Dual-Tasking Abilities Using a Novel E-Health Device—A Proof of Concept Study in Multiple Sclerosis

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach

The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod

PANGAEA 2.0: State of the Art Multiple Sclerosis Patient Management in Daily Clinical Practice. A 3-Year Observational Study of Patients Receiving Fingolimod (P3.031)

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

TREAT-MS Study of Real-World Effectiveness of Alemtuzumab in RRMS Patients in Germany: Subgroup Analysis by Timing of Treatment Initiation (170)

Umsetzung der Nationalen VersorgungsLeitlinie (NVL) zur Therapie des Diabetes mellitus Typ 2 in diabetologischen Schwerpunktpraxen

Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple Sclerosis

Real-World Effectiveness of Alemtuzumab in Relapsing-Remitting MS Patients in Germany: Interim Results of the TREAT-MS Study (P3.2-057)

Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approach

Design of a Non-interventional Study to Establish Effectiveness, Quality of Life, Cognition, Health-Related and Work Capacity Data on Alemtuzumab in Multiple Sclerosis Patients in Germany (TREAT-MS) (P7.281)

Umsetzung der Nationalen VersorgungsLeitlinie (NVL) zur Therapie des Diabetes mellitus Typ 2 in diabetologischen Schwerpunktpraxen: Hohe Übereinstimmung im therapeutischen Alltag

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System

Multiple Sclerosis Documentation System MSDS3D - Innovative Management of Patients with Multiple Sclerosis (I8-1.003)

Multiple Sclerosis Documentation System MSDS3D - Innovative Management of Patients with Multiple Sclerosis (P3.130)

Implementation of the National Guidelines for the treatment of Diabetes mellitus type 2 in secondary diabetes centers

Limited Time from the Diabetes Patients' Perspective: Need for Conversation with the Eye Specialist

Suchergebnisse filtern